#blueribbonfail
In a parallel universe of #BlueRibbonPanel, Incremental HD win over HDF and then Tubular Toxins win over Incremental HD.Completely opposite to the crowd's vote. An outrageous series of #BlueRibbonFail . #NephMadness @lauraratcliffe7.bsky.social @nephmadness.bsky.social
April 4, 2025 at 9:29 PM
Amazing how closely the crowd and Blue Ribbon panel voted. Only three exceptions really (EU/US hyponatremia guidelines, culture-negative peritonitis/catheter-dysfunction in PD, and gadolinium/ iodinated contrast in CKD 4). Probably can't call it a #BlueRibbonFail #NephMadness
November 23, 2024 at 2:17 AM
It's not surprising that we often get it wrong relying on traditional volume measures when we think about the margins involved - UF volume equalling total plasma volume. As much as I love clinical examination, if old school progresses it will be a #BlueRibbonFail. #NephMadness
November 23, 2024 at 12:14 AM
2. Is this surprising? Hypertension has form in #NephMadness, with JNC8 beating the KDIGO Hypertension guidelines in 2014 and ultimately progressing to overall winner. In 2016 hypertension for CKD beat CVD in a #BlueRibbonFail (where’s the data?). US beat EU last year
November 22, 2024 at 11:55 PM
Non-steroidal MRAs 9-0?

No immunosuppression in IgA 7-2?

Shocking #BlueRibbonFail 😂🤔
November 22, 2024 at 11:34 AM
But I still dislike iHD and agree it’s another #BlueRibbonFail. Probable that Oates character…
April 2, 2025 at 10:06 PM
Busted bracket blues
#Effluent8 not that great
"Arooooo" means adieu

#MedHaiku #BlueRibbonFail #TeamVirallyInfectedKidneys #houndswillbeback2019 #NephMadness @NephMadness @AJKDonline
November 23, 2024 at 12:46 AM
@NephRodby - we know you're not kidnapped yet, since #NephMadness hasn't officially started. Before the inevitable #NephGate3 and #BlueRibbonFail happen, show us your loudest pair of socks to help us #SockItToKidneyDisease!
November 22, 2024 at 11:28 AM
US HTN Guidelines as the #NephMadness winner? A boring #BlueRibbonFail.
November 22, 2024 at 10:05 AM
November 22, 2024 at 9:58 AM
The biggest #BlueRibbonFail of #NephMadness is CAR-T. Very cool immunology, perhaps useful in extremely severe autoimmunity, but overall impact on nephrology? Next to nil. Too toxic, too hard to scale.
two men are sitting at a table in a bowling alley with the words `` am i wrong ? '' above them .
ALT: two men are sitting at a table in a bowling alley with the words `` am i wrong ? '' above them .
media.tenor.com
April 7, 2025 at 12:29 PM
#nephMadness looks like PRO will win after all. 🤦🏻‍♂️ I truly hope that the driving stimulus for the selection was not political correctness. For ESRD care, yes PRO. But for CKD progression?? Plz. #whatajoke #letsgetreal #beingofftarget #blueribbonfail
December 18, 2024 at 9:48 PM
A #BlueRibbonPanel member said “I’ve never seen eculizumab play”?? OMG. We are talking about one of the new 7 wonders in nephrology here. A promising thing was chosen over an existing miracle drug? Utterly incomprehensible. Complete and catastrophic #BlueRibbonFail #NephMadness
December 18, 2024 at 12:47 AM
Agreed! I'm right up there (down there) with you at rank 617 #blueribbonfail
April 7, 2025 at 6:37 PM
Household competition with bragging right on the line.

#nephmadness #blueribbonfail ⁦@TeamBear22⁩ ⁦@teamnmbear⁩ #animalhouse
November 17, 2024 at 12:13 AM
ICIs over nonsteroidal MRAs is an absolute travesty. You can argue with the merits of finerenone vs spironolactone but not with the impact on CKD therapy. #nephmadness #BlueRibbonFail
November 16, 2024 at 7:13 PM
This is a real travesty #nephmadness #blueribbonfail. The question isn’t what side of the fence you’re on, it’s what’s going to impact the field and you can’t argue that the new papers, methodology flaws or not, haven’t spurred discussion/re-examining of a tenet of Nephrology
November 16, 2024 at 1:56 PM
just as big a #BlueRibbonFail as from #NephMadness 2019 when US #hypertension guidelines was champion, 👀🙄😂😂😀
April 7, 2025 at 4:19 PM
yea, agreed… we chose Natural Disasters because the #BlueRibbonPanel often has a strong US bias… makes sense given the platform though.
Remember the HUGE #BlueRibbonFail outrage of 2019 when US Htn g/l’s was #NephMadness Champion, 👀😳🙄😱🤦🏼‍♀️🤷🏼‍♀️😂
ajkdblog.org/2019/04/08/n...
#NephMadness 2019 Champion: US Hypertension Guideline
On March 15th, we revealed the 32 teams grouped into 8 regions competing in this year’s NephMadness. For the last 3 weeks we have heard from expert after expert on which team should win it al…
ajkdblog.org
April 3, 2025 at 6:25 PM
They do incremental in PD though, so why not in HD too… for ppl who aren’t eligible for PD.

Not a #BlueRibbonFail at all, 🤓😃
April 2, 2025 at 2:12 PM
No, not a #BlueRibbonFail at all!
Incremental dialysis is a part of individualized patient care.
HDF is out, 🤓😃😅😂
bsky.app/profile/sara...
see?!?, HDF is #UNCONVINCING & old news.. & why incremental dialysis *will* advance in the #NephMadness bracket!!
For middle molecules, Hdx MCO- expanded HD therapy w/ medium cut-off membrane- potentially results in better clinical outcomes than HDF, 👀🤓😀

journals.sagepub.com/doi/epub/10....
Expanded hemodialysis: a new concept of renal replacement therapy
journals.sagepub.com
April 2, 2025 at 1:19 PM
Incremental 👍👍🙏
No #BlueRibbonFail there!, 😃
HDF is old news, 🙄 it ended before it started; ppl are moving on to incremental dialysis &/or expanded HD (HDx therapy) now, #NephMadness
April 2, 2025 at 12:32 PM
Remember the #NephMadness 2021 huge #BlueRibbonFail when the Implantable Bioartificial Kidney team was Champion?
It will feel like that again if the BRPanel picks renal denervation rather than the meds. with the GLP1 inhibitors.
Definitely need (more than, lol) 2 brackets, 🤓🤔
#NephMadnessThrowbacks
kermit the frog is holding his hand to his mouth and looking surprised .
Alt: kermit the frog is holding his hand to his mouth and looking surprised .
media.tenor.com
March 15, 2025 at 3:27 AM
sounds like this region might result in a (nice) #BlueRibbonFail 😂😂🙏
March 7, 2025 at 2:16 AM